Novartis in alliance to target the proteome

Novartis has announced a new academic alliance to explore the proteome as a source of new drug leads for cancer and other serious diseases. The collaboration is with the University of California Berkeley, US.

Full text available to subscribers only. Click here for information on subscribing to MedNous.


United States